Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 14/20 | 0.70 |
| ▸ | CYP11B2 | P19099 | 12/20 | 0.70 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.70 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.56 |
| ▸ | QPCT | Q16769 | 1/20 | 0.56 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.56 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.56 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.55 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31060578 | 0.96 | CYP11B1 (0.70) | CYP11B1CYP11B2ADRA2CCYP19A1CYP1A2 | |
| SCHEMBL28101470 | 0.90 | CYP11B1 (0.74) | CYP11B1CYP11B2CYP19A1CYP1A2POLB | |
| SCHEMBL19223688 | 0.88 | CYP11B1 (0.60) | CYP11B1CYP11B2ADRA2CCYP19A1CYP1A2 | |
| SCHEMBL17974017 | 0.88 | CYP11B1 (0.78) | CYP11B1CYP11B2ADRA2CCYP19A1CYP1A2 | |
| SCHEMBL17923065 | 0.88 | CYP11B1 (0.63) | CYP11B1CYP11B2ADRA2CCYP19A1CYP1A2 | |
| SCHEMBL22485661 | 0.85 | CYP11B1 (0.62) | CYP11B1CYP11B2ADRA2CCYP19A1CYP1A2 | |
| SCHEMBL21854602 | 0.84 | CYP11B1 (0.56) | CYP11B1CYP11B2ADRA2CCYP19A1CYP1A2 | |
| SCHEMBL21711995 | 0.83 | TBXAS1 (0.58) | CYP11B1CYP11B2ADRA2CCYP19A1TBXAS1 | |
| SCHEMBL1848631 | 0.82 | CYP11B1 (1.00) | CYP11B1CYP11B2ADRA2CCYP19A1CYP1A2 | |
| SCHEMBL707075 | 0.81 | CYP11B1 (1.00) | CYP11B1CYP11B2ADRA2CCYP19A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9611279-B2 | Zinc complex | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2017-04-04 | — | — | US | disclosed |
| US-9611279-B2 | Zinc complex | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2017-04-04 | — | — | US | disclosed |
| US-20160002268-A1 | ZINC COMPLEX | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-01-07 | — | — | US | disclosed |
| US-20160002268-A1 | ZINC COMPLEX | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160002268-A1 | ZINC COMPLEX | SLC39A11, SLC39A3, SOD1 | CYP11B1 3357/4885CYP11B2 3467/4885ADRA2C 4106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.